EAEU Medical Device Registration and Authorized Representative Russia
Enter a single regulatory bloc of 180M+ people across Russia, Belarus, Kazakhstan, Armenia and Kyrgyzstan where most high technology devices are imported. NexorTest delivers end-to-end market access: Roszdravnadzor (RZN) national registration, EAEU five market registration, independent Russian Authorized Representative (RUS REP) services, local accredited lab testing, and full Russian language dossier preparation all under one expert roof.
Four EU Aligned Device Classes Under Russian & EAEU Law
Russia and the EAEU use a four class risk model mirroring the EU. Your class determines the depth of testing, whether a manufacturing QMS inspection applies, and the clinical evaluation burden.
Class 1 Devices
Low risk devices such as non-invasive instruments, bandages, and basic consumables. Lightest documentation burden and the fastest national review clinical trials are not normally required.
- Fastest Review
- No QMS Inspection
- Indefinite Validity
Class 2a Devices
Moderate risk devices such as many electromedical, diagnostic and reusable devices. Local technical, biological and EMC testing apply; sterile Class 2a additionally triggers a manufacturing QMS inspection.
- Local Testing
- Sterile = Inspection
- EMC for Electrical
Class 2b Devices
Higher risk devices including many implantables and longer term contact devices. Full technical and biological testing, a mandatory manufacturing QMS inspection, and clinical evaluation are expected.
- QMS Inspection
- Clinical Evaluation
- Post-Market Reports
Class 3 Devices
The highest risk, life supporting or life sustaining devices. Expect the fullest dossier, mandatory manufacturing inspection, and in many cases a Russian clinical study for EAEU, multicenter trials across member states.
- Clinical Study
- Up to 2 Years
- Multicenter (EAEU)
Two Routes to Market: National vs EAEU
Russia offers two parallel registration tracks. Choosing the right one driven by your target countries and device class determines whether you secure one market or all five, and how fast.
Roszdravnadzor (RZN) National
Registration under Government Decree No. 1684 (effective March 2025). Produces an RZN Registration Certificate valid for an indefinite period but recognized in Russia only. Faster to scope for a Russia first launch; requires a Russian Authorized Representative, local testing, and a QMS inspection for sterile 2a / 2b / 3 devices. Full projects typically run 6-15 months including testing.
EAEU Unified Registration
Registration under EEC Council Decision No. 46. One certificate recognized across Russia, Belarus, Kazakhstan, Armenia and Kyrgyzstan. You select a Reference State (lead regulator) and States of Recognition. Larger dossier (30 documents) and harmonized testing, with multicenter clinical trials for Class 2b/3 but the strategic choice for true regional access to 180M+ people.
Comprehensive Russia & CIS Regulatory Services
From classification and Authorized Representative services through vigilance, NexorTest manages every aspect of your Roszdravnadzor and EAEU regulatory journey.
Roszdravnadzor (RZN) Registration
Complete national RZN Registration Certificate for Class 1, 2a, 2b, and 3 medical devices and IVDs under Decree 1684. We manage classification, nomenclature coding, dossier preparation, Gosuslugi submission, fees, and query resolution end to end.
EAEU 5 Market Registration
Unified Eurasian Economic Union registration under EEC Decision 46. We select the optimal Reference State, coordinate States of Recognition, and assemble the 30 document harmonized dossier so one program opens Russia, Belarus, Kazakhstan, Armenia and Kyrgyzstan.
Russian Authorized Representative
Independent RUS REP / EAEU Authorized Representative services. NexorTest holds your registration neutrally, manages all Roszdravnadzor interactions, and lets you appoint or change importers and distributors freely without losing control of your certificate.
AR Update 1 Sept 2026 Deadline
Government Decree No. 1206 requires foreign manufacturers to update Authorized Representative details by 1 September 2026 or risk suspension and cancellation of existing certificates. We run the administrative update submission and take over as your compliant AR.
Local Accredited Lab Testing
Russia requires in-country testing even with FDA or CE approval. We coordinate technical, biological (ISO 10993) and EMC testing in accredited labs, manage sample shipment, and align existing IEC 60601 / ISO 10993 data to minimize repeat work.
Sample Import Permit Management
Before testing, device samples must be imported under a Roszdravnadzor import permit and cleared through Russian customs. We prepare and submit the import permit application and handle the customs documentation so testing starts without delay.
GOST ISO 13485 Inspection Support
For sterile Class 2a, all Class 2b and Class 3 devices, a manufacturing-site QMS inspection against GOST ISO 13485 is mandatory. We run gap analysis, prepare your site and documentation, and support the inspection to a clean outcome.
Russian Dossier & Translation
Russian language dossier preparation to Ministry of Health requirements, with certified translation, notarization and apostille of foreign documents, plus high resolution color label mockups and 'Honest Sign' digital marking compliance the details that prevent rejection.
IVD Registration Russia & EAEU
In Vitro Diagnostic registration across the four class framework, including analytical and clinical laboratory performance evaluation and reagent documentation. IVDs follow a distinct testing route and are exempt from EAEU technical testing.
SaMD & AI Software (Order 181n)
Software as a Medical Device strategy for Russia: lifecycle and validation documentation, cybersecurity requirements, and the mandatory AI/ML declaration under Ministry of Health Order 181n including the data-transmission obligation for AI-enabled medical software.
Vigilance & Post-Market
Post-market surveillance including incident reporting, field safety corrective actions, per unit import notification within 15 days, annual post market clinical monitoring for Class 3 and 2b implants, and amendment management to keep your certificate active.
CIS & Multi-Market Expansion
Coordinate Russia and the EAEU alongside neighbouring CIS markets and your global portfolio from a single integrated program ideal for manufacturers planning a regional Eurasian and CIS launch strategy.
Your Trusted Russia & EAEU Specialist
We combine an on the ground Moscow regulatory team with global reference market expertise to deliver faster, more predictable Roszdravnadzor and EAEU approvals.
Russian Native Moscow Regulatory Team
Russian speaking specialists who know the Gosuslugi platform, Roszdravnadzor reviewers, and the VNIIIMT / NIK expert centres first hand
National vs EAEU Strategy Done Right
We map your target countries, class and timeline to the right route fast Russia first RZN or the five market EAEU dossier so you never over build or under scope your filing.
Independent AR You Keep Control
We hold your registration as a neutral Russian Authorized Representative, so you can change importers and distributors anytime without your certificate being held hostage by a commercial partner.
2026 Deadline & Local Testing Logistics
We keep you ahead of the 1 September 2026 AR update deadline (Decree 1206) and manage sample import, accredited lab testing and inspection readiness end to end.
Transparent Fixed Fee Packages
Our fixed fee scopes cover strategy, AR, testing coordination, dossier, submission, and post market support, with clear milestones and deliverables.
Six Steps to Your Registration Certificate
A proven, structured approach that minimizes information requests and accelerates your path to the Russian and EAEU medical device market.
Classification & Pathway Strategy
We confirm your risk class (1, 2a, 2b, or 3) and nomenclature code, then choose between national Roszdravnadzor registration and EAEU five market registration based on your target countries, class, and timeline setting realistic milestones from day one.
Appoint Russian Authorized Rep
NexorTest is appointed as your independent RUS REP / EAEU Authorized Representative via a notarized, apostilled power of attorney. We set up the Gosuslugi applicant account and all legal documentation.
Sample Import & Local Testing
We secure the import permit, ship samples through customs, and run mandatory technical, biological (ISO 10993) and EMC testing in Russian accredited labs required even with existing FDA or CE approval.
Dossier Preparation in Russian
We compile and translate the dossier technical and operational documentation, risk analysis, ISO 13485 / GOST evidence, test and clinical reports, Certificate of Free Sale, apostilled documents, and compliant Russian labeling with color mockups.
Submission, Inspection & Queries
We submit electronically via Gosuslugi to Roszdravnadzor or the EAEU Reference State, coordinate the GOST ISO 13485 manufacturing inspection for sterile 2a / 2b / 3 devices, and manage every information request within the response windows.
Certificate & Post-Market
You receive your indefinite validity RZN or EAEU Registration Certificate. We set up vigilance, per unit import notification, and post market clinical monitoring, and manage amendments and AR updates throughout the lifecycle.
Roszdravnadzor & EAEU Expertise Across Every Device Category
From implantables to digital health, our regulatory specialists cover the full breadth of medical technology entering the Russian and Eurasian market.
- 🫀 Cardiovascular & Implants
- 🧬 In Vitro Diagnostics
- 💻 SaMD & AI Software
- 🩻 Imaging & Radiology
- 🦴 Orthopaedics
- 💉 Infusion & Drug Delivery
- 🩸 Surgical Instruments
- 👁 Ophthalmics
- 🦷 Dental Devices
- 🏥 Electro-Medical Equipment
- 📱 Wearables & Remote Monitoring
- 🔬 Laboratory Equipment
Frequently Asked Questions for EAEU Medical Device Registration Russia
What is Roszdravnadzor medical device registration in Russia?
Roszdravnadzor (RZN) registration is the mandatory state market authorization issued by the Federal Service for Surveillance in Healthcare, Russia’s medical device and IVD regulator under the Ministry of Health. Every device imported into or sold in Russia must hold a valid RZN Registration Certificate before commercialization. The current framework is Government Decree No. 1684 (effective 1 March 2025), replacing Decree No. 1416 of 2012. The process involves classification (Class 1, 2a, 2b, or 3), appointment of a Russian Authorized Representative for foreign manufacturers, sample import, mandatory local testing, a Russian-language dossier, electronic submission via Gosuslugi, and a QMS inspection for sterile 2a / 2b / 3 devices. The national certificate is valid for an indefinite period and covers Russia only.
What is the difference between national (RZN) and EAEU registration?
There are two parallel routes. National Roszdravnadzor registration under Decree 1684 produces an RZN certificate valid indefinitely but recognized only in Russia. EAEU registration under EEC Council Decision No. 46 produces one certificate recognized across all five member states Russia, Belarus, Kazakhstan, Armenia, and Kyrgyzstan (180M+ people). Under EAEU you choose a Reference State (lead regulator) and States of Recognition. EAEU requires a larger dossier (30 documents vs 11), harmonized testing, and multicenter clinical trials for Class 2b/3, so it takes longer but unlocks five markets. National filings remain available in parallel within the transition window. NexorTest advises which route fits your class, target countries, and timeline.
What is a Russian Authorized Representative (RUS REP)?
A Russian Authorized Representative (RUS REP / AR) is a legal entity or individual entrepreneur registered in Russia that a foreign manufacturer appoints to represent its interests in device circulation, conformity assessment, and state registration. Foreign manufacturers cannot apply to Roszdravnadzor directly appointing an AR is a legal prerequisite, and the certificate may be issued in the AR’s name. The AR submits applications, manages sample import, communicates with Roszdravnadzor and expert centres, handles vigilance, and manages amendments. A critical 2026 requirement: existing registrations must update AR details by 1 September 2026 (Decree No. 1206) or risk suspension/cancellation. NexorTest provides independent AR services, holding your registration neutrally so you keep full freedom to change importers and distributors.
Does Russia require local testing even with FDA or CE approval?
Yes, Unlike many markets, Russia and the EAEU require in-country testing in locally accredited laboratories even if a device already holds US FDA 510(k) clearance or EU CE marking. Required tests can include technical testing, biological/biocompatibility evaluation aligned with ISO 10993, electromagnetic compatibility (EMC) for electrical devices, and metrological type approval for measuring instruments. Existing ISO 10993 or IEC 60601 reports can support the dossier but do not replace Russian tests. Samples must be imported under an import permit before testing. For sterile Class 2a, all Class 2b and Class 3 devices, a GOST ISO 13485 manufacturing inspection is also mandatory. NexorTest coordinates import, testing, and inspection readiness end to end.
How long does Russia / EAEU registration take?
For national Roszdravnadzor registration, the official expert review is about 31 working days without clinical trials and around 50 working days with them, but the full project including dossier prep, sample import, local testing, and clinical evaluation typically runs 6 to 15 months by class, and up to about 2 years for complex or innovative Class 3 devices needing a Russian clinical study. EAEU registration is more document intensive: a turnkey project usually takes 9 to 15 months, extending to 18-24 months for implantable, Class 3, or complex IVD systems. Documentation completeness and testing lead time are the biggest drivers; our pre-submission review minimizes information requests that pause the clock.
What documents are required for registration?
A Russian dossier typically includes the application and a notarized, apostilled power of attorney appointing the AR product description, technical and operational documentation, drawings and specifications description of raw materials and manufacturing process; an ISO 13485 / GOST ISO 13485 certificate (mandatory for sterile 2a, 2b and 3) risk analysis; biological, technical and EMC test reports from Russian accredited labs; clinical or clinical laboratory evaluation as required; a Certificate of Free Sale and reference market approvals (FDA, CE); and Russian language labeling and IFU with high resolution color mockups. All foreign documents must be translated into Russian by a certified translator and notarized/apostilled. EAEU submissions add 30 documents including a post-market surveillance plan and the manufacturing inspection report. NexorTest prepares and quality checks the full dossier.
When does the national to EAEU transition happen?
The EAEU has been moving toward a single registration system since 2022, with the transition repeatedly extended. National and EAEU tracks currently run in parallel within statutory timeframes, and existing national certificates issued before the cut-over remain valid (with amendment windows continuing for a defined period after). Because exact dates have shifted several times and depend on the latest EEC protocols and Russian decrees, the practical answer is: file now on whichever route fits your strategy, and don’t assume a national certificate will be accepted indefinitely for new submissions. NexorTest tracks every protocol update and times your filing so you are never caught by a closing window. Contact us for the current status for your device class.
What is the cost of registration in Russia?
Costs include Roszdravnadzor state fees, local testing, optional clinical evaluation, inspection fees, translation, AR fees, and consulting. State fees are modest and fixed by risk class the expert review duty broadly ranges from roughly 45,000 to 115,000 rubles, plus a fixed certificate issuance duty. The dominant cost drivers are mandatory Russian lab testing and, for sterile 2a / 2b / 3 devices, the manufacturing-site inspection. As a result, an all in single product national registration commonly runs around USD 10,000-15,000, with EAEU and Class 3 / clinical study projects costing more. NexorTest provides a transparent, project specific fixed fee quote covering strategy, AR, testing coordination, dossier, submission, and post market support. Contact us for a free cost assessment.
Ready to Enter the EAEU Medical Device in Russian Market?
Get a free regulatory assessment from specialists in Russia and Eurasian market access. Our experts will map your fastest compliant route national RZN or EAEU five market to a Registration Certificate, and keep you ahead of the 1 September 2026 AR deadline.